No Results
"We are currently gathering more data to assess the safety of firstwordpharma.com. Your safety is our priority, and we're conducting a thorough analysis before providing a comprehensive evaluation."
FirstWord Pharma - Your source for disease area news and pharma industry intelligence on biosimilars, market access, medical affairs, orphan drugs, pharma marketing, R&D, regulatory.
Traffic rank of firstwordpharma.com, compared to all other sites
↓ 340K+
United States
Website ranking is crucial for evaluating firstwordpharma.com's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, firstwordpharma.com's global ranking has decreased from 478,644 to 818,328.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to firstwordpharma.com based on traffic, content and site structure.
Essential business intelligence for biopharma executives, managers, investors, scientists and regulators to manage the translation of science into medicine.
Biocentury alternatives
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
Biopharmadive alternatives
The Home of the Life Sciences Industry. Find biotech, clinical research and pharmaceutical jobs from thousands of employers.
Biospace alternatives
Trusted commercial intelligence, consensus forecasts, Vantage news and analysis for pharma, biotech and medtech industry - Explore Evaluate
Evaluategroup alternatives
Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D.
Fiercebiotech alternatives
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Fiercepharma alternatives
The PharmaTimes portfolio includes the well-respected monthly PharmaTimes Magazine; three news elert services; business forums, where thought-leaders meet to discuss the issues of the day; and a series of awards that recognise, reward and celebrate excellence.
Pharmatimes alternatives
Up to date news for the pharmaceutical and biotechnology industries - The Pharma Letter
Thepharmaletter alternatives
Are you human?.
Dmaconstructionct alternatives
FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Finlegal alternatives
Check out some of our popular sites.